1. Home
  2. MLEC vs BCTX Comparison

MLEC vs BCTX Comparison

Compare MLEC & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moolec Science SA

MLEC

Moolec Science SA

HOLD

Current Price

$0.25

Market Cap

2.6M

Sector

Finance

ML Signal

HOLD

Logo BriaCell Therapeutics Corp.

BCTX

BriaCell Therapeutics Corp.

HOLD

Current Price

$7.13

Market Cap

17.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLEC
BCTX
Founded
2008
2014
Country
Cayman Islands
Canada
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6M
17.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MLEC
BCTX
Price
$0.25
$7.13
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$40.00
AVG Volume (30 Days)
359.4K
71.0K
Earning Date
01-30-2026
12-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$20.42
N/A
Revenue Next Year
$30.00
$380.95
P/E Ratio
N/A
N/A
Revenue Growth
170.36
N/A
52 Week Low
$0.21
$6.00
52 Week High
$8.00
$98.20

Technical Indicators

Market Signals
Indicator
MLEC
BCTX
Relative Strength Index (RSI) 31.56 38.04
Support Level $0.21 $6.90
Resistance Level $0.32 $7.77
Average True Range (ATR) 0.05 0.76
MACD -0.00 -0.26
Stochastic Oscillator 15.74 12.12

Price Performance

Historical Comparison
MLEC
BCTX

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: